Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearing out, ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

The FDA declared the end of the shortage of Novo Nordisk’s Wegovy and Ozempic, impacting compounding pharmacies selling ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their employers. Weight-loss drugs are increasingly popular among employees ...

Weight-loss drugs are increasingly popular among employees but weigh heavily on health-insurance budgets. Popular weight-loss drugs such as Ozempic, Wegovy and Zepbound are a growing factor in ...

Rob and Julia Campbell/Stocksy Aging and limited physical activity, as well as the use of novel weight loss drugs such as Wegovy and Zepbound, often lead to the simultaneous loss of muscle mass ...

The company created its GLP-1 Insurance Checker specifically to help you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll even ...

Covering some 1.9million people in the UK, private health insurer Vitality has become the country’s first provider to offer customers discounted weight-loss treatments, such as Wegovy and Mounjaro.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.